All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Fat loss comparison

AOD-9604 vs Semaglutide

An educational, source-based comparison of AOD-9604 and Semaglutide — how each peptide works, what it's researched for, and what to know before going deeper.

Metabolic · Lipolysis
AOD-9604

Modified GH fragment researched for adipose tissue effects.

Mechanism

A modified 16-amino-acid fragment (177–191) of human growth hormone, engineered to retain the lipolytic activity of GH without its growth or insulin-resistance effects. Research suggests it stimulates lipolysis and inhibits lipogenesis.

Research areas
  • Obesity (clinical trials did not meet endpoints)
  • Osteoarthritis / cartilage repair (current research direction)
  • Localized adipose research
Considerations
  • Not FDA-approved as a therapeutic.
  • Has GRAS status in some food contexts (Australia), not equivalent to drug approval.
Full AOD-9604 profile →
Metabolic · Incretin
Semaglutide

FDA-approved GLP-1 agonist for diabetes and obesity.

Mechanism

A long-acting GLP-1 receptor agonist that enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite via central GLP-1 receptors.

Research areas
  • Type 2 diabetes (Ozempic, Rybelsus)
  • Obesity / chronic weight management (Wegovy)
  • Cardiovascular risk reduction (SELECT trial)
Considerations
  • FDA-approved with established safety profile but real side effects (GI, pancreatitis risk, gallbladder events).
  • Requires physician oversight and prescription.
  • Compounded versions vary in quality.
Full Semaglutide profile →

AOD-9604 vs Semaglutide — Key differences

  • Class: AOD-9604 is classified as Metabolic · Lipolysis, while Semaglutide is Metabolic · Incretin.
  • Primary research focus: AOD-9604obesity (clinical trials did not meet endpoints); Semaglutidetype 2 diabetes (ozempic, rybelsus).
  • Tag: Fat loss vs Weight loss.

Related comparisons